Evidence map›Paper›PMID 16810523›Full record

ArticleIntensive care medicine2006

Platelet and soluble CD40L in meningococcal sepsis.

David P Inwald, Saul N Faust, Paula Lister, Mark J Peters, Michael Levin, Robert Heyderman, Nigel J Klein

Abstract read
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. An Insight into Recent Advances on Platelet Function in Health and Disease.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Observational
  7. Review
  8. Rac1 regulates platelet shedding of CD40L in abdominal sepsis.Laboratory investigation; a journal of technical methods and pathology · 2014
    Article
  9. Metalloproteinases regulate CD40L shedding from platelets and pulmonary recruitment of neutrophils in abdominal sepsis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2012
    Article
  10. Article
  11. Microvascular thrombosis and CD40/CD40L signaling.Journal of thrombosis and haemostasis : JTH · 2011
    Article
  12. Article
  13. Soluble CD40L (CD154) is increased in patients with shock.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2010
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

David P InwaldDepartment of Paediatrics, Faculty of Medicine, Imperial College of Science, Technology & Medicine, St Mary's Campus, W2 1PG, London, UK. David.Inwald@st-marys.nhs.uk
Saul N Faust
Paula Lister
Mark J Peters
Michael Levin
Robert Heyderman
Nigel J Klein
Institute of Child Health · GRImperial College London · GBNIHR Wellcome Trust Southampton Clinical Research Facility · GBUniversity of Bristol · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine the influence of meningococcal sepsis on levels of platelet derived CD40L and on endothelial CD40 expression. DESIGN AND

settingProspective observational study in two tertiary paediatric intensive care units. PATIENTS AND

participants63 children with meningococcal sepsis and 10 age-matched controls. MEASUREMENTS AND

results(a) sCD40L ELISA of plasma from patients with meningococcal sepsis (n = 49) and age matched controls (n = 10). This demonstrated higher sCD40L levels in patients (median 0.29 ng/ml, IQR 0.2-0.41) than controls (0.09 ng/ml, 0.08-0.12). However, there was no relationship between plasma sCD40L level and platelet count or disease severity. (b) Flow cytometry of fresh blood from patients with meningococcal sepsis (n = 11) and age-matched controls (n = 10) for membrane bound CD40L and CD62P on circulating platelets. This demonstrated low levels of CD40L and CD62P in patients and controls. CD40L+ platelets were 3.5% (3.0-4.8) in patients and 4.9% (3.5-4.3) in controls. CD62P+ platelets were 10.7% (6.4-12.8) in patients and 7.9% (5.9-13.0) in controls. (c) Immunohistochemistry of skin biopsy specimens from six patients, staining for endothelial CD40 expression at sites of microthrombus formation, which demonstrated preserved CD40 expression in vascular endothelium at sites of microthrombus formation.

conclusionsThe elevated sCD40L level in meningococcal sepsis implies release of sCD40L from platelets. However, there was no relationship between plasma sCD40L level and the degree of thrombocytopenia or disease severity. Furthermore, platelet surface bound CD40L was similar in controls and patients. Thus, further investigation is needed to determine whether platelet CD40L contributes to inflammation and thrombosis in MCS.

Indexed as

Case-Control StudiesCD40 LigandChildFemaleFlow CytometryHumansImmunohistochemistryMaleMeningococcal InfectionsPlatelet CountProspective StudiesStatistics, NonparametricCD40 Ligand

Identifiers

PMID16810523
OpenAlexW2059743853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.